Topical Vitamin C for Treatment of Basal Cell Cancer

• Status: Completed
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Center for Biomedical Research, Inc.
• Treatments: Ascorbic Acid

Criteria

Inclusion Criteria:

• Presence of biopsy proven basal cell carcinoma

Exclusion Criteria:

• Absence of basal cell carcinoma